Virtual Medicinal Product (VMP) - Generic Eviplera 200mg/25mg/245mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Generic Eviplera 200mg/25mg/245mg tablets | Start Date 01-06-2012 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Never Valid To Prescribe As A VMP
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- Other
Codes
- ATC Code
- J05AR08
| BNF | Start Date | End Date |
|---|---|---|
| Current BNF 05030100 | Start Date 04-04-2022 | End Date |
| Previous BNF 05030100 | Start Date 04-12-2012 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 20594611000001108 | 01-06-2012 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Emtricitabine | Based on Ingredient Substance | 200 mg | ||
| Rilpivirine hydrochloride | Based on Base Substance | Rilpivirine | 25 mg | |
| Tenofovir disoproxil | Based on Ingredient Substance | 245 mg |
Name
Emtricitabine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
200
Strength and UOM (Dmr)
Name
Rilpivirine hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Rilpivirine
Strength and UOM (Nmr)
25
Strength and UOM (Dmr)
Name
Tenofovir disoproxil
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
245
Strength and UOM (Dmr)
Parent Products
-
VTMTenofovir disoproxil + Emtricitabine + Rilpivirine
-
VMP(Current) Generic Eviplera 200mg/25mg/245mg ta...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 30 tablet |